Table 2 Assessment of attitude about the criteria used drug formulary selection
Criteria used in drug formulary selection | Mean | ± SD | Median | influential/very influential | |
|---|---|---|---|---|---|
F | (%) | ||||
1. Number, frequency and severity of adverse drug reactions | 4.31 | 0.86 | 5 | 696 | 80.4 |
2. Safety or frequency and severity of toxicity | 4.37 | 0.83 | 5 | 712 | 82.2 |
3. Antibiotic resistance | 4.35 | 0.84 | 5 | 706 | 81.5 |
4. Clinical evidence-based effectiveness in scientific literature | 4.27 | 0.84 | 4 | 694 | 80.1 |
5. Effect of the drug on the quality of life | 4.33 | 0.84 | 5 | 713 | 82.3 |
6. Medical specialists clinical expertise | 4.23 | 0.86 | 4 | 687 | 79.3 |
7. Use in children or neonates | 4.21 | 0.95 | 5 | 660 | 76.2 |
8. Number and severity of contraindications | 4.29 | 0.86 | 5 | 696 | 80.4 |
9. Specific characteristics of hospital patient population | 4.12 | 0.92 | 4 | 645 | 74.5 |
10. Drug–drug interaction | 4.29 | 0.88 | 5 | 686 | 79.2 |
11. Therapeutic window | 4.21 | 0.86 | 4 | 672 | 77.6 |
12. Use during childish, pregnancy, and lactation | 4.28 | 0.88 | 5 | 687 | 79.3 |
13. Drug–food interactions | 4.24 | 0.88 | 4 | 679 | 78.4 |
14. New and innovative pharmacological effect | 4.17 | 0.89 | 4 | 663 | 76.6 |
15. Number of (un)registered indications | 4.07 | 0.93 | 4 | 629 | 72.6 |
16. Contents of sodium chloride, sugars, and lactose | 4.01 | 0.98 | 4 | 605 | 69.9 |
17. Selected drug cost | 4.16 | 0.87 | 4 | 659 | 76.1 |
18. Presence of alternatives in the current formulary | 4.17 | 0.88 | 4 | 655 | 75.6 |
19. Potential of patient/staff abuse of the drug | 4.13 | 0.94 | 4 | 640 | 73.9 |
20. Evidence-based practice ( approved treatment protocols) | 4.29 | 0.85 | 5 | 688 | 79.4 |
21.Patients convenience/patients adherence | 4.23 | 0.86 | 4 | 673 | 77.7 |